Pitch Day - Thursday, July 02, 2026

Daten zeigen, dass die Behandlung mit Visugromab in Kombination mit dem Anti-PD-1-Antikörper Nivolumab eine tiefgreifende und dauerhafte antitumorale Aktivität erzielt.

BU EN

Application for start-ups until July 07, 2026:

Apply now and present your technology to leading life science investors and decision makers in pharma and VC companies. Become one of the ten start-ups that get the opportunity to pitch!

Here’s how it works: Submit a non-confidential summary or presentation of your start-up or a project that you would like to spin off from your research institution by 07 June 2026. Please use the following link: Life Science Pitch Day 2026

AGENDA

Registration and questions on the event

Are you an investor and would like to register or do you have questions about the Pitch Day?

Dr. Christian Kannemeier, Senior Investment Manager and Calvin Kunth, Junior Analyst at HTGF, will be happy to help you. Please contact them via c.kunth@htgf.de.

Location

Innovations-und Gründerzentrum
Biotechnologie (IZB)
Am Klopferspitz 21
82152 Planegg-Martinsried bei München

Room:
Faculty Club G2B, 7th floor in the
IZB Residence CAMPUS AT HOME

With support of

Grafik zum Life Science Pitch Day 2026: Text auf Verlaufshintergrund